About AERI

Aerie is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie recently reported the successful results of its second Phase 3 registration trial in the United States named Rocket 2, where the primary efficacy endpoint was to demonstrate non-inferiority of IOP lowering for Rhopressa compared to timolol. Rocket 3, a 12-month safety-only study, is currently in progress, and Aerie has recently commenced a fourth Phase 3 trial for Rhopressa, named Rocket 4. Aerie also completed in 2014 a Phase 2b clinical trial in which Roclatan met the primary efficacy endpoint, demonstrating the statistical superiority of Roclatan to each of its components, and recently commenced the first Phase 3 registration trial for Roclatan, named Mercury 1. Aerie also recently announced research collaborations with GrayBug, Inc. and Ramot at Tel Aviv University as it further builds its pipeline for future growth.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Biological Product (except Diagnostic) Manufacturing

AERI is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.40497E+09 1,988 1988 0.01% 0.000122 168 K 167620
FTLS First Trust Long/Short Equity 183.6 M 1.83635E+08 269 269 -0.07% -0.0007 -125 K -125183
IBB iShares Nasdaq Biotechnology Index Fund 7.3 B 7.34933E+09 222 222 0.25% 0.0025 18.7 M 1.86914E+07
IHE iShares U.S. Pharmaceutical ETF 346.2 M 3.46181E+08 45 45 0.67% 0.0067 2.3 M 2344870
ITOT iShares Core S&P Total U.S. Stock Market ETF 19.5 B 1.95299E+10 3,547 3547 0.01% 0.0001 1.1 M 1134350
IWM iShares Russell 2000 ETF 40.5 B 4.05202E+10 1,989 1989 0.07% 0.0007 29.6 M 2.96404E+07
IWO iShares Russell 2000 Growth ETF 8.8 B 8.79796E+09 1,232 1232 0.14% 0.0014 12.2 M 1.21988E+07
IWV iShares Russell 3000 ETF 9.1 B 9.10141E+09 2,929 2929 0.0% 0 448 K 447908
JKK iShares Morningstar Small-Cap Growth ETF 202.9 M 2.02929E+08 243 243 0.26% 0.0026 537 K 537354
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 356 356 0.04% 0.000411311 625 K 625435
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.02% 0.000185257 389 K 389394
BIB ProShares Ultra Nasdaq Biotechnology 223.8 M 2.2382E+08 239 239 0.11% 0.00109291 512 K 512247
UBIO Proshares UltraPro Nasdaq Biotechnology 28.3 M 2.82606E+07 228 228 0.07% 0.000721529 63 K 63459
URTY ProShares UltraPro Russell2000 85.2 M 8.5176E+07 2,005 2005 0.02% 0.000180387 49 K 49261
UWM ProShares Ultra Russell2000 181.5 M 1.8146E+08 2,006 2006 0.02% 0.000247776 101 K 100611